You are here: Industry Insights > trial

News List

COVID-19 vaccine trials data should be made public: Medicos Association expresspharma
January 18, 2021
They said that the decision to grant EUA may be revisited once the Phase 3 trials are completed.
China’s CAS COVID-19 vaccine induces immune response in mid-stage tests expresspharma
December 24, 2020
A coronavirus vaccine candidate developed by the Chinese Academy of Sciences (CAS) was found to be safe and triggered immune responses in early and mid-stage trials, researchers said on Tuesday.
Volunteers in Russia’s Sputnik V vaccine trials will no longer receive placebos – RIA expresspharma
December 24, 2020
Moscow’s Gamaleya Institute, the developer of the first Russian vaccine against COVID-19, said on Wednesday that volunteers in its large-scale final-stage trials for the Sputnik V shot will no longer receive placebos, RIA news agency reported.
CureVac initiates Phase IIb/III trial of Covid-19 vaccine candidate pharmaceutical-technology
December 16, 2020
German company CureVac has enrolled the first participant in the pivotal Phase IIb/III HERALD study to evaluate the safety and efficacy of its mRNA vaccine candidate, CVnCoV, against Covid-19.
SIFI Completes Enrollment for Acanthamoeba Keratitis Study americanpharmaceuticalreview
December 07, 2020
SIFI has achieved the full enrollment of 135 patients with Acanthamoeba keratitis (AK) in its pivotal Phase III clinical trial (043/SI).
J&J to test COVID-19 vaccine in youths aged 12-18 expresspharma
November 02, 2020
Johnson & Johnson plans to start testing its experimental COVID-19 vaccine in youths aged 12 to 18 as soon as possible, and the company’s previous experience with the same technology in a vaccine successfully used in children could give it a leg up ...
Nanoformed formulation of piroxicam to enter Phase I trials europeanpharmaceuticalreview
October 23, 2020
The first-in-human clinical trial of nanoformed piroxicam will begin in late 2020, with results expected by mid-2021.
Boehringer Ingelheim Enrolls First Patient to Evaluate nintedanib for Pediatric Fibrosing ILD americanpharmaceuticalreview
August 17, 2020
Boehringer Ingelheim announced the first patient has enrolled in InPedILD™, a global Phase III trial assessing the dosing and safety profile of nintedanib in children and adolescents between 6 and 17 years old with clinically significant fibrosing ...
Direct Biologics Receives FDA Approval to Initiate “EXIT-COVID-19” Drug Trial americanpharmaceuticalreview
August 06, 2020
Direct Biologics has received approval from FDA that it may proceed with a Phase II trial under an Investigational New Drug (IND) application for the use of ExoFlo™, a bone marrow-derived extracellular vesicle and exosome product, in the treatment of ...
Promise and prevention: Experts discuss the race for a COVID-19 vaccine expresspharma
July 24, 2020
As the global race for a COVID-19 vaccine heats up, Reuters invited a group of healthcare experts to answer questions as part of our #AskReuters Twitter chat series.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 13 Next page